Search

Search Constraints

You searched for: Author/Creator MacManus, David

Search Results

3. Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial. Issue 3 (March 2020)

5. Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study. Issue 9 (September 2021)

6. Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study. (March 2022)

7. Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis. (26th April 2022)

8. Remyelination varies between and within lesions in multiple sclerosis following bexarotene. Issue 10 (17th September 2022)

9. Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. Issue 8 (30th August 2018)